N°2

A d v a n c e d A e s t h e t i c Te c h n o l o g i e s , I n c - O n e B r o o k l i n e P l a c e , S u i t e 4 2 7 - B r o o k l i n e , M A 0 2 4 4 5 - w w w . a l g e n e s s . c o m - i n f o @ a l g e n e s s . c o m

TESTIMONIALS

“

“

”

”

I have been using non-surgical

methods such as dermal fillers

in my practice for more than 15

years in conjunction with aes-

thetic and plastic surgery proce-

dures.

I have many years of experience

with dermal fillers and during this

time I have used many different

types of products, however the

Algeness® filler I have been

using for almost 2 years now has

enabled me to introduce incre-

dible innovations in my medical

practice and offers me many new

opportunities.

Due to its extraordinary reliability

and unique physical structure, I

am able to use Algeness® filler

for functional and reconstructive

procedures as well as aesthetic

corrections.

This completely natural volu-

mizer, which can also be consi-

dered an “injectable implant”, is

also used functionally to cover

bone, cartilage

and soft tissue

defects and

facial deficien-

cies as well as

other parts of

the body.

I also use

Algeness®

for correcting

secondary

deformities after a non-surgi-

cal rhinoplasty procedure. With

a new approach I functionally

expand the nasal valve angle and

reduce alar collapses by using it

to support the alar wings.

Algeness is a unique volumizer,

due to its structure and low mi-

gration properties it can also be

used for bone remodeling and

replacement of volume loss and

bone resorp-

tion resulting

from aging.

It is an ama-

zing mate-

rial for bone

remodeling in

frontal, maxil-

lary, zygoma-

tic, paranasal,

mandibular

and mentum areas and produces

results that both my patients and

I are extremely satisfied with.

I believe that shaping and

contouring are more important

objectives in aesthetic applica-

tions rather than just “filling”.

The number of patients I treat is

increasing day by day ever since

I choose to use Algeness® in

place of aesthetic implants in the

jaw and malar regions due to its

lower cost, durability, safety, no

downtime and excellent contou-

ring and shaping capabilities.

Algeness® is totally safe, rever-

sible, non-allergenic and 100%

biodegradable. It produces im-

mediate and stable results due to

its hydrocolloid structure. Alge-

ness is now a very important part

of my clinical practice.D R . Ö M E R B U H S E M

“I USE ALGENESS FOR RECONSTRUCTIVE PROCEDURES”

“THE CLINICAL RESULTS ARE ABSOLUTELY INCREDIBLE”

N E W SALGENESS®

100% NATURAL & ADAPTABLE INJECTABLE IMPLANT

•

•

•

•

•

•

•

•

•

••

•

•

•

•

•

••

As an aesthetic surgeon I

have more than twenty years

of experience in the use of

hyaluronic acid fillers.

During these years, in my Skin

Laser Clinics, I have taken care

of thousands of patients for

the treatment of aesthetic and

volumetric corrections of the

face and lips by developing

a considerable expertise

for hyaluronic acid injection

techniques, but recently I

understood that it was necessary

to find a product that could

overcome the duration limits of

these products and the possible

formation of granulomas.

Therefore, after some initial

hesitation about using

Algeness®, a filler composed of

purified agarose, I documented

the structural biochemical and

molecular characteristics of the

product and consequently the

different implant techniques.

In this regard, I would like to

take advantage of this means of

communication to clarify some

of the concepts of Algeness®

that I’ve learned during my 24

months of experience so that all

my colleagues can appreciate

the unique features of this

technologically innovative filler.

First of all,

Algeness

is a 100%

natural and

biodegradable

filler;

histological

and

immunohisto

chemical

clinical

studies show that, in contrast

to other fillers, Algeness® does

not stimulate flogistic reactions

and contrary to collagen or

Hyaluronic acid products,

Algeness produces minimal

capsular reactions thanks to the

fact that Algeness gel does not

contain any additional chemical

substances or crosslinking agents

so the resorption is total and

complete.

The clinical results are absolutely

incredible and using a minimum

quantity of product you can

obtain natural and immediate

volumizing results.

From a practical point of view

there is

only a slight

difference in

the injection

technique of

Algeness®

versus HA due

to the different

gel density

and depth of

injection.

This specific technique can be

learned in the MASTER YOUR

RESULTS Training course where

experienced Experts teach the

correct injection and remodeling

techniques in order to

immediately obtain the desired

results.

Moreover with Algeness®, a

purified agarose injectable

implant, it’s possible to treat in

an excellent way all areas of the

face: from the forehead to the

zygomatic malar areas, from

the lips to rinofiller applications,

taking maximum advantage of

the hydrocolloid chacteristics

of the agarose, and thanks

to the fact that Algeness® is

not hydrophilic the results are

immediate and definitive.

Moreover since agarose does

not tend to migrate, it renders

Algeness® a perfect product to

use in particular in areas where

it’s essential to have molecular

stability, for example for the

correction of the nasal profile.

To conclude the results

obtained using Algeness, have

a duration of more than 12

months and thanks to the total

biocompatibility of this product

the side effects are minimal and

the patient can return to their

normal activities immediately

after the treatment.

FA B I O M A R I N I

FOCUS ON TEAR TROUGH INJECTION

Master Your Results®

A G A R O S E M O L E C U L E

OH

OH HOn

H OO

OO

O

OH

OH

TEAR TROUGH INJECTION PROTOCOL

2/ Cannula Technique:

For experienced and expert

injectors.

Advantages: minimal tissue

trauma, minimal bruising.

Disadvantages: more expertise

required to position the cannula.

Important notice: a cannula 27

may work best to fill a hollow

close to the medial canthal

tendon insertion or at the lateral

condensation, or to reach a

submuscular position around

a superomedial orbital hollow.

Nevertheless, injection risks

are higher with a small calibre

cannula.

Local anaesthesia

and vasoconstriction

of cannula entrance points:

Luer lock syringe 1 ml.

Needle 33 G.

Lidocaine2% with adrenaline

1/200.000.

0,1 to 0,2 ml per point.

Immediate subdermal and

intradermal injections.

I - Inferior orbital margin.

Access point on the meridian

of the orbit, 5 mm caudal to

the hollow, allowing finger

compression for hemostasis

without displacing the product.

Cannula 27. All passages are to be

made deep to the orbicularis oculi

muscle. First passage towards

inner canthal ligament, either

cranial or caudal to orbicularis

oculi insertion.

Aspiration. Slow and careful,

retrograde injection of 0,1 to 0,25 ml.

If a hollow remains at the other

side of the orbicularis insertion, a

second passage, more cranial or

caudal respectively, is required,

as the product cannot be rubbed

through a muscle insertion.

Short passage to the meridian

of the orbital margin. Aspiration.

Slow bolus injection of no more

than 0,05 ml, to be repeated if

necessary.

Passage over the inferolateral

orbital margin.

Aspiration. Slow and careful,

retrograde injection of 0,1 to 0,25 ml.

Gently remodel and massage at

the end of the treatment.

II - Superior orbital margin

Access point at the transition

between the eyelid and the

eyebrow, superolateral.

Cannula 27. All passages are to

be made deep to the orbicularis

oculi muscle and superficial to the

orbital septum. One passage into

the A-frame area.

Aspiration. Slow and careful,

retrograde injection of 0,1 to 0,3 ml.

Gently remodel and massage at

the end of the treatment.

INDICATIONS:

I - Inferior Orbital Margin.

1. Excessively deep inferome-

dial orbital margin contour

(deep orbital part of tear

trough).

2. Excessively deep inferior

orbital margin contour .

II - Superior Orbital Margin

3. Medial hollowing of upper

eyelid (A-frame deformity)

4. Hollowing of entire upper

eyelid.

The first indication to consider

are volume deficits in patients

with a tendency towards pe-

riorbital œdema (malar mounds,

eyelid œdema) or a known ten-

dency to develop oedema around

the orbital margin after hyaluro-

nic acid injections.

ANATOMY:

Good anatomical knowledge on

periocular innervation, vascularisa-

tion, the orbital septum, the zygo-

maticocutaneous and orbicularis

retaining ligaments, the orbicularis

oculi muscle including its bony

insertions, the canthal tendons,

the lateral condensation and the

superficial and deep periorbital fat

compartments is a prerequisite.

INJECTION PLANE:

It is strongly recommanded to

inject Algeness LD Charm 1% for

tear trough correction deep to

the orbicularis oculi muscle only INJECTION TECHNIQUE:

1/ Sharp Technique:

For experienced injectors at the

beginning of their learning curve

on the orbital margin.

For expert injectors who prefer

the sharp approach.

Advantages: maximum control

of the position of the tip of the

needle.

Disadvantages: superficial

product spread along needle

canal, higher chance of bruising.

Compound Algeness LD Charm1%

with 0,2 ml of lidocaine 2% with

adrenaline 1/200.000 for pain

reduction and vasoconstriction.

Perform multiple punctures along

the volume deficit.

Position the tip of the needle

under the orbicularis oculi muscle

down to the bone.

Gently remodel and massage at

the end of the treatment.

Avoid repeated puncturing at the

same spot, as reactive oedema

and bleeding limits visual control.

Remain aware of the cellular

response to Algeness and avoid

all subcutaneous or intradermal

injection in the periorbital area.

A L G E N E S S L D C H A R M 1 %

“longer lasting, safe, fully resorbable filler

Does not cause œdema or unpredictable changes after injection”

> 18-20 May 2018

SIME39th National Congress

of the Italian Society of

Aesthetic Medicine

Rome / Italy

> 28 April- 1 May

RADLALatin America Dermatology

Congress

Cancún - Mexico

> 6-8 April 2018

AMWCAnti Aging Medicine World

Congress

Monte Carlo /Monaco

> 19-21 March 2018

DUBAI DERMADubai World Dermatology

and Laser Conference &

Exhibition. Dubai - UAE

> 23-25 February 2018

SIES21st International Congress

of Aesthetic Medicine and

Surgery. Bologna /Italy

> February 2018

Algeness International MeetingBologna / Italy

> 1-3 February 2018

IMCASWorld Congress

Paris / France

> 15-16 September 2017

AMEC & VISAGEMonte-Carlo/Monaco

> 12-14 May 2017

SIME38th National Congress

of the Italian Society of

Aesthetic Medicine

Rome / Italy

> 6-8 April 2017

AMWCAnti Aging Medicine World

Congress

Monte-Carlo / Monaco

ALGENESS EVENTS

EDITORIAL

Our exhibit at the AMWC-Visage Conference in Monte Carlo

marks the 18th month since we introduced the Algeness®

program of excellence “Master Your Results”®. Designed to

advance the skills of professionals for consistently excellent

outcomes for their patients with the all-natural 100%

biodegradable Algeness®, the program has exceeded our

expectations.

By the end of 2017 Algeness® will be available in over 30

countries in Europe, Asia, South America, and the Middle East.

We were especially honored to have a family of dedicated and

enthusiastic distributors committed to bring this all-natural gel

implant technology to clinicians in their countries. Now more

than ever, clinicians are choosing Algeness® for its immediate

results, ability to remodel and shape, and to have the peace of

mind knowing it is all-natural with no added chemicals.

We are also extremely proud of our clinicians who have

shared with us their experiences with Algeness® and we have

responded by the introduction of Algeness® LD Charm 1% for

the tear trough and lip augmentation area during the AMWC-

Visage Conference in September. Now whether it is for lifting

and volumizing, facial correction, lip augmentation, or treating

the sensitive area of the tear trough, Algeness® can be your

choice for discerning patients.

Clearly, we are committed to delivering on our mission to the

aesthetic community of an all-natural gel implant solution

without additives or chemicals to produce excellent outcomes

for a youthful natural look. Thus, we are excited and energized

by the rapid growth of the Algeness® family and the clinical

solutions available by the Algeness ® technology. To be a part of

this family, please contact us through our website: Algeness.com

or directly at info@algeness.com.

R ICHARD BURTTEXECUTIVE CHAIRMAN

Advanced Aesthetic

Technologies, Inc. USA

Algeness-Europe,

Ltd, Ireland

•

•

•

•

•

•

•

•

•

•

••

•

•

•

•

•

••

Zygomatico

cutaneous

ligament

Levator labilsuperioris muscle

OrbicularisOculi muscle

1/ PALPEBROMALAR GROOVE

2/ NASOJUGAL GROOVE

3/ MID CHEEK GROOVE

1 2

3

FOCUS

...

...

Dr. Arna Shab - Germany

ALGENESS 100% CHEMICAL FREETHE MOST PURE AND SAFE ADAPTABLE IMPLANT FOR YOUR PATIENT’S NATURAL LOOK.

CLASS 1

LIMITED TO TEAR TROUGH

CLASS II

EXTENDED LATERALLY

CLASS III

FULL

N E W

Algeness Training Website

Register onhttp://training.algeness.com

Zygomaticusminor muscle

Orbitomalar

ligament

1/ Intraorbital fat

(lower eyelid)

2/ Infraorbital fat

(malar mound)

3/ Lateral soof

4/ Medial soof

5/ Medial cheek fat

1

234

5